Transjugular Intrahepatic Portosystemic Shunt Linked to Increased Risk of Hepatocellular Carcinoma: A VA Matched Cohort Study

Shalini Bansal; Tamar Taddei; Rebecca Wells; Marina Serper; Theresa Bittermann; Nadim Mahmud; David E Kaplan

doi:10.14218/JCTH.2023.00554

Transjugular Intrahepatic Portosystemic Shunt Linked to Increased Risk of Hepatocellular Carcinoma: A VA Matched Cohort Study

J Clin Transl Hepatol. 2024 May 28;12(5):534-538. doi: 10.14218/JCTH.2023.00554. Epub 2024 Apr 8.

Authors

Shalini Bansal¹, Tamar Taddei^{2

3}, Rebecca Wells^{2

3}, Marina Serper^{2

3}, Theresa Bittermann^{2

3}, Nadim Mahmud^{2

3

4

5}, David E Kaplan^{2

3}

Affiliations

¹ Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA.
² Division of Gastroenterology and Hepatology Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
³ Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, USA.
⁴ Division of Gastroenterology and Hepatology, Yale University School of Medicine, New Haven, CT, USA.
⁵ VA Connecticut Healthcare System, West Haven, CT, USA.

No abstract available